Susquehanna International Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,201
Closed -$588K 10497
2018
Q4
$588K Buy
+4,201
New +$638K ﹤0.01% 5720
2018
Q3
Sell
-23,231
Closed -$3.9M 10797
2018
Q2
$4.03M Buy
+23,231
New +$3.49M ﹤0.01% 2994
2017
Q1
Sell
-21,623
Closed -$694K 10570
2016
Q4
$694K Buy
+21,623
New +$554K ﹤0.01% 6299
2014
Q4
Sell
-11,310
Closed -$149K 10343
2014
Q3
$149K Buy
+11,310
New +$147K ﹤0.01% 8890

Other funds holding LOXO

Susquehanna International Group's LOXO Position: Q1 2019 in Review

Susquehanna International Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,201 shares — an estimated $588K sold.

Susquehanna International Group first reported a position in LOXO in Q3 2014 and held it in 4 quarters. The position peaked at $4.03M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Susquehanna International Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Susquehanna International Group sold 4,201 Loxo Oncology, Inc shares in Q1 2019, an estimated $588K.
  • Susquehanna International Group first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 4 quarters.
  • Susquehanna International Group's Loxo Oncology, Inc position peaked at $4.03M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.